Injury programmes shape glioblastoma

Speaker: Prof. Simona Parrinello, UCL Cancer Institute, London, UK

Abstract: Glioblastoma is the most common and aggressive primary brain cancer in adults and is almost universally fatal due to its stark therapeutic resistance. During the past decade, although survival has not substantially improved, major advances have been made in our understanding of the underlying biology. It has become clear that these devastating tumors recapitulate features of neurodevelopmental hierarchies which are influenced by the microenvironment. Emerging evidence also highlights a prominent role for injury responses in steering cellular phenotypes and contributing to tumor heterogeneity. This review highlights how the interplay between injury and neurodevelopmental programs impacts on tumor growth, invasion, and treatment resistance, and discusses potential therapeutic considerations in view of these findings.

Introductory talk: “Nano-Omics for blood biomarker discovery in Glioblastoma” by Dr Anita Liu (NanoOmics Team, Nanomedicine Lab, University of Manchester, UK)